首页 > 最新文献

Health affairs scholar最新文献

英文 中文
Comparing HEDIS Performance of Dual Eligible Special Needs Plans to Other Coverage Types for Dually Eligible People 比较双合格特殊需求计划与其他双合格人群保险类型的 HEDIS 业绩
Pub Date : 2024-03-20 DOI: 10.1093/haschl/qxae036
Amelia M Haviland, Megan Mathews, Steven C. Martino, Yvette Overton, Jacob W Dembosky, Jessica Maksut, Marc N. Elliott
People eligible for both Medicare and Medicaid coverage (“dually eligible individuals”) have lower levels of income and assets and often higher health care needs and costs than those eligible for Medicare but not Medicaid coverage. Their three most common Medicare coverage options are: Medicare Advantage (MA) Dual Eligible Special Needs Plans(D-SNP), non-D-SNP MA plans, and fee-for-service (FFS) Medicare with a stand-alone prescription drug plan. No prior study has examined clinical quality of care for dually eligible individuals across these three coverage types. To fill that void, we used logistic regression to compare these coverage types on six HEDIS measures of clinical quality of care that were available for both MA and FFS (constructed from claims files). D-SNP and non-D-SNP MA plans significantly outperformed FFS for all six measures for dually eligible individuals, by approximately 5 percentage points for two measures and by 18-34 percentage points for the other four measures. For the four measures with the greatest advantage over FFS, performance was 3-8 percentage points higher in D-SNP than in non-D-SNP MA plans.
与那些有资格享受 "医疗保险 "但不享受 "医疗补助计划 "的人员相比,同时有资格享受 "医疗保险 "和 "医疗补助计划 "的人员("双重资格人员")的收入和资产水平较低,医疗保健需求和费用通常较高。他们最常见的三种医疗保险选择是他们最常见的三种联邦医疗保险选择是:联邦医疗保险优势计划(MA)"双重资格特殊需求计划"(D-SNP)、非 "双重资格特殊需求计划 "MA 计划,以及带有独立处方药计划的付费服务(FFS)联邦医疗保险。此前还没有研究对这三种保险类型中符合双重资格者的临床护理质量进行过调查。为了填补这一空白,我们使用逻辑回归法对这些承保类型的六项 HEDIS 临床护理质量指标进行了比较,这六项指标同时适用于 MA 和 FFS(根据索赔档案构建)。对于符合双重资格的个人而言,D-SNP 和非 D-SNP 医保计划在所有六项指标上的表现均明显优于 FFS,其中两项指标优于 FFS 约 5 个百分点,其他四项指标优于 FFS 18-34 个百分点。在与 FFS 相比优势最大的四项指标中,D-SNP 的绩效比非 D-SNP MA 计划高出 3-8 个百分点。
{"title":"Comparing HEDIS Performance of Dual Eligible Special Needs Plans to Other Coverage Types for Dually Eligible People","authors":"Amelia M Haviland, Megan Mathews, Steven C. Martino, Yvette Overton, Jacob W Dembosky, Jessica Maksut, Marc N. Elliott","doi":"10.1093/haschl/qxae036","DOIUrl":"https://doi.org/10.1093/haschl/qxae036","url":null,"abstract":"\u0000 People eligible for both Medicare and Medicaid coverage (“dually eligible individuals”) have lower levels of income and assets and often higher health care needs and costs than those eligible for Medicare but not Medicaid coverage. Their three most common Medicare coverage options are: Medicare Advantage (MA) Dual Eligible Special Needs Plans(D-SNP), non-D-SNP MA plans, and fee-for-service (FFS) Medicare with a stand-alone prescription drug plan. No prior study has examined clinical quality of care for dually eligible individuals across these three coverage types. To fill that void, we used logistic regression to compare these coverage types on six HEDIS measures of clinical quality of care that were available for both MA and FFS (constructed from claims files).\u0000 D-SNP and non-D-SNP MA plans significantly outperformed FFS for all six measures for dually eligible individuals, by approximately 5 percentage points for two measures and by 18-34 percentage points for the other four measures. For the four measures with the greatest advantage over FFS, performance was 3-8 percentage points higher in D-SNP than in non-D-SNP MA plans.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"331 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140227769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-evaluation of the methodology for estimating the U.S. specialty physician workforce 重新评估美国专科医生队伍的估算方法
Pub Date : 2024-03-19 DOI: 10.1093/haschl/qxae033
W. S. Black-Schaffer, David J Gross, Z. Nouri, Aidan DeLisle, Michael Dill, Jason Y Park, James M Crawford, Michael B Cohen, Rebecca L Johnson, Donald S Karcher, Thomas M Wheeler, Stanley J Robboy
Increasing pursuit of subspecialized training has quietly revolutionized physician training, but the potential impact on physician workforce estimates has not previously been recognized. The Physicians Specialty Data Reports of the Association of American Medical Colleges, derived from specialty designations in the American Medical Association Physician Professional Data (PDP), are the reference source for US physician workforce estimates; by 2020 the report for pathologists is an undercount of 39% when compared to the PDP. Most of the difference was due to omission of pathology subspecialty designations. The rest resulted from reliance on only the first of the AMA Physician Professional Data’s two specialty data fields. Placement of specialty designation in these two fields is sensitive to sequence of training and is thus affected by multiple or intercalated (between years of residency training) fellowships. Both these phenomena have become progressively more common and are not unique to pathology. Our findings demonstrate the need to update definitions and methodology underlying estimates of the US physician workforce for pathology and suggest a like need in other specialties affected by similar trends.
对亚专业化培训的日益追求已悄然为医生培训带来了革命性的变化,但其对医生队伍估算的潜在影响却尚未被认识到。美国医学院协会的医生专业数据报告来自美国医学会医生专业数据(PDP)中的专业名称,是美国医生劳动力估算的参考来源;到 2020 年,病理学家的报告与 PDP 相比少计了 39%。大部分差异是由于遗漏了病理学亚专业名称。其余的原因则是只依赖 AMA 医生专业数据的两个专业数据字段中的第一个字段。这两个字段中的专科指定位置对培训顺序很敏感,因此会受到多重或插班(住院医师培训的间隔年)研究金的影响。这两种现象已变得越来越普遍,并非病理学所独有。我们的研究结果表明,有必要更新美国病理学医生队伍的定义和估算方法,并表明受类似趋势影响的其他专科也有同样的需求。
{"title":"Re-evaluation of the methodology for estimating the U.S. specialty physician workforce","authors":"W. S. Black-Schaffer, David J Gross, Z. Nouri, Aidan DeLisle, Michael Dill, Jason Y Park, James M Crawford, Michael B Cohen, Rebecca L Johnson, Donald S Karcher, Thomas M Wheeler, Stanley J Robboy","doi":"10.1093/haschl/qxae033","DOIUrl":"https://doi.org/10.1093/haschl/qxae033","url":null,"abstract":"\u0000 Increasing pursuit of subspecialized training has quietly revolutionized physician training, but the potential impact on physician workforce estimates has not previously been recognized. The Physicians Specialty Data Reports of the Association of American Medical Colleges, derived from specialty designations in the American Medical Association Physician Professional Data (PDP), are the reference source for US physician workforce estimates; by 2020 the report for pathologists is an undercount of 39% when compared to the PDP. Most of the difference was due to omission of pathology subspecialty designations. The rest resulted from reliance on only the first of the AMA Physician Professional Data’s two specialty data fields. Placement of specialty designation in these two fields is sensitive to sequence of training and is thus affected by multiple or intercalated (between years of residency training) fellowships. Both these phenomena have become progressively more common and are not unique to pathology. Our findings demonstrate the need to update definitions and methodology underlying estimates of the US physician workforce for pathology and suggest a like need in other specialties affected by similar trends.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"16 s3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140229821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Domestic violence: prevention past due. 家庭暴力:预防逾期。
Pub Date : 2024-03-19 eCollection Date: 2024-04-01 DOI: 10.1093/haschl/qxae034
Debbie I Chang

In May 2023, the White House released the National Plan to End Gender-Based Violence, which includes intimate partner or domestic violence (DV). Based on 20 years of experience in California, this commentary provides detailed examples of 2 DV prevention strategies: interrupting intergenerational transmission and addressing macrolevel drivers. Family-strengthening approaches to prevention and justice and increasing economic security are key. Insight into regional policies and programs can inform implementation of the national plan and DV prevention in other states and localities.

2023 年 5 月,白宫发布了《结束性别暴力国家计划》,其中包括亲密伴侣或家庭暴力 (DV)。根据加利福尼亚州 20 年的经验,本评论提供了 2 个家庭暴力预防战略的详细示例:阻断代际传播和解决宏观层面的驱动因素。加强家庭的预防和司法方法以及提高经济安全是关键。对地区政策和计划的深入了解可以为国家计划的实施以及其他州和地方的家庭暴力预防工作提供参考。
{"title":"Domestic violence: prevention past due.","authors":"Debbie I Chang","doi":"10.1093/haschl/qxae034","DOIUrl":"https://doi.org/10.1093/haschl/qxae034","url":null,"abstract":"<p><p>In May 2023, the White House released the National Plan to End Gender-Based Violence, which includes intimate partner or domestic violence (DV). Based on 20 years of experience in California, this commentary provides detailed examples of 2 DV prevention strategies: interrupting intergenerational transmission and addressing macrolevel drivers. Family-strengthening approaches to prevention and justice and increasing economic security are key. Insight into regional policies and programs can inform implementation of the national plan and DV prevention in other states and localities.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"2 4","pages":"qxae034"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Locations and characteristics of pharmacy deserts in the United States: A geospatial study 美国药房沙漠的位置和特征:地理空间研究
Pub Date : 2024-03-16 DOI: 10.1093/haschl/qxae035
R. Wittenauer, P. Shah, J. Bacci, Andy Stergachis
Pharmacies are important healthcare access points, but no national map currently exists of where pharmacy deserts are located. This cross-sectional study used pharmacy address data and Census Bureau surveys to define pharmacy deserts at the census tract level in all 50 US States and DC. We also compared sociodemographic characteristics of pharmacy desert vs. non-pharmacy desert communities. Nationally, 15.8 million (4.7%) of all people in the US live in pharmacy deserts, spanning urban and rural settings in all 50 states. On average, communities that are pharmacy deserts have a higher proportion of people who: have a high school education or less, have no health insurance, have low self-reported English ability, have an ambulatory disability, and identify as a racial or ethnic minority. While, on average, pharmacies are the most accessible healthcare setting in the US, many people still do not have access to them. Further, the people living in pharmacy deserts are often marginalized groups who have historically faced structural barriers to healthcare. This study demonstrates a need to improve access to pharmacies and pharmacy services to advance health equity.
药房是重要的医疗保健接入点,但目前还没有全国性的药房荒漠分布图。这项横断面研究利用药店地址数据和人口普查局调查,在美国 50 个州和华盛顿特区的人口普查区一级界定了药店荒。我们还比较了药店荒与非药店荒社区的社会人口特征。从全国范围来看,美国有 1580 万人(4.7%)生活在药荒地区,遍布 50 个州的城市和农村。平均而言,药房荒漠社区中以下人群的比例较高:高中或以下学历、没有医疗保险、自我报告的英语能力较低、有行动障碍以及被认定为少数种族或少数族裔。虽然平均而言,药房是美国最方便的医疗机构,但仍有许多人无法获得药房服务。此外,生活在药房沙漠中的人往往是边缘化群体,他们历来面临着医疗保健的结构性障碍。这项研究表明,有必要改善药房和药房服务的可及性,以促进健康公平。
{"title":"Locations and characteristics of pharmacy deserts in the United States: A geospatial study","authors":"R. Wittenauer, P. Shah, J. Bacci, Andy Stergachis","doi":"10.1093/haschl/qxae035","DOIUrl":"https://doi.org/10.1093/haschl/qxae035","url":null,"abstract":"\u0000 Pharmacies are important healthcare access points, but no national map currently exists of where pharmacy deserts are located. This cross-sectional study used pharmacy address data and Census Bureau surveys to define pharmacy deserts at the census tract level in all 50 US States and DC. We also compared sociodemographic characteristics of pharmacy desert vs. non-pharmacy desert communities. Nationally, 15.8 million (4.7%) of all people in the US live in pharmacy deserts, spanning urban and rural settings in all 50 states. On average, communities that are pharmacy deserts have a higher proportion of people who: have a high school education or less, have no health insurance, have low self-reported English ability, have an ambulatory disability, and identify as a racial or ethnic minority. While, on average, pharmacies are the most accessible healthcare setting in the US, many people still do not have access to them. Further, the people living in pharmacy deserts are often marginalized groups who have historically faced structural barriers to healthcare. This study demonstrates a need to improve access to pharmacies and pharmacy services to advance health equity.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"54 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140237200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Highest Cost Medicaid Enrollees with Sickle Cell Disease Had Annual Health Care Expenditures Nearing $200 000 费用最高的镰状细胞病医疗补助计划参保者每年的医疗支出接近 200 000 美元
Pub Date : 2024-03-11 DOI: 10.1093/haschl/qxae029
Junelle Speller, Sarah Rayel, Kristen Hayashi, Michaela Kirby, Dianne Munevar, A. Hartzman, Kevin Dietz
Sickle cell disease (SCD) is a painful chronic blood disorder that causes serious complications and comorbidities, often leading to premature death. SCD impacts millions of people worldwide, including an estimated 100 000 in the United States, most of whom are Black or Latino. We analyzed Medicaid enrollment, claims, and encounter data via the Transformed Medicaid Statistical Information System (T-MSIS) to examine the 2021 health care utilization and spending of Medicaid enrollees with SCD. Our analysis found that Medicaid enrollees with SCD have high annual medical and pharmacy expenditures that are not evenly distributed across the population. Among the most severe, clinical trial eligible enrollees, those in the top 5% of health care spending incurred, on average, nearly $200 000 per year for this chronic condition.
镰状细胞病 (SCD) 是一种令人痛苦的慢性血液疾病,会引起严重的并发症和合并症,通常会导致患者过早死亡。SCD 影响着全球数百万人,包括美国约 10 万人,其中大部分是黑人或拉丁裔。我们通过 "转型医疗补助统计信息系统"(T-MSIS)分析了医疗补助的注册、报销和就诊数据,以检查患有 SCD 的医疗补助注册者 2021 年的医疗保健使用和支出情况。我们的分析发现,患有 SCD 的医疗补助参保者每年的医疗和药房支出很高,而这些支出在整个人群中的分布并不均匀。在病情最严重、符合临床试验条件的参保者中,医疗保健支出最高的 5%的参保者平均每年因这一慢性病花费近 20 万美元。
{"title":"The Highest Cost Medicaid Enrollees with Sickle Cell Disease Had Annual Health Care Expenditures Nearing $200 000","authors":"Junelle Speller, Sarah Rayel, Kristen Hayashi, Michaela Kirby, Dianne Munevar, A. Hartzman, Kevin Dietz","doi":"10.1093/haschl/qxae029","DOIUrl":"https://doi.org/10.1093/haschl/qxae029","url":null,"abstract":"\u0000 Sickle cell disease (SCD) is a painful chronic blood disorder that causes serious complications and comorbidities, often leading to premature death. SCD impacts millions of people worldwide, including an estimated 100 000 in the United States, most of whom are Black or Latino. We analyzed Medicaid enrollment, claims, and encounter data via the Transformed Medicaid Statistical Information System (T-MSIS) to examine the 2021 health care utilization and spending of Medicaid enrollees with SCD. Our analysis found that Medicaid enrollees with SCD have high annual medical and pharmacy expenditures that are not evenly distributed across the population. Among the most severe, clinical trial eligible enrollees, those in the top 5% of health care spending incurred, on average, nearly $200 000 per year for this chronic condition.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"80 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140251808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unmet need for mental health care is common across insurance market segments in the United States. 在美国,未得到满足的心理健康护理需求在各个保险细分市场都很普遍。
Pub Date : 2024-03-08 eCollection Date: 2024-03-01 DOI: 10.1093/haschl/qxae032
Mark K Meiselbach, Catherine K Ettman, Karen Shen, Brian C Castrucci, Sandro Galea

A substantial proportion of individuals with depression in the United States do not receive treatment. While access challenges for mental health care have been documented, few recent estimates of unmet mental health needs across insurance market segments exist. Using nationally representative survey data with participant-reported depression symptom severity and mental health care use collected in Spring 2023, we assessed access to mental health care among individuals with similar levels of depression symptom severity with commercial, Medicare, Medicaid, and no insurance. Among individuals who reported symptoms consistent with moderately severe to severe depression, 37.8% did not have a diagnosis for depression (41.0%, 28.1%, 33.6%, and 56.3% with commercial, Medicare, Medicaid, and no insurance), 51.9% did not see a mental health specialist (49.7%, 51.7%, 44.9%, and 91.8%), and 32.4% avoided mental health care due to affordability in the past 12 months (30.2%, 34.0%, 21.1%, and 54.8%). There was substantial unmet need for mental health treatment in all insurance market segments, but especially among individuals without insurance.

在美国,有相当一部分抑郁症患者没有接受治疗。虽然心理健康医疗的可及性问题已被记录在案,但最近很少有关于各保险细分市场未满足的心理健康需求的估算。我们使用 2023 年春季收集的具有全国代表性的调查数据,包括参与者报告的抑郁症状严重程度和心理保健使用情况,评估了具有相似抑郁症状严重程度的个人在商业保险、医疗保险、医疗补助和无保险情况下获得心理保健的情况。在报告症状符合中度至重度抑郁症的人群中,37.8% 的人没有抑郁症诊断(41.0%、28.1%、33.6% 和 56.3%,包括商业保险、医疗保险、医疗补助和无保险),51.9% 的人没有看心理健康专科医生(49.7%、51.7%、44.9% 和 91.8%),32.4% 的人在过去 12 个月中因经济能力问题而避免了心理健康护理(30.2%、34.0%、21.1% 和 54.8%)。在所有的保险市场细分中,都有大量的心理健康治疗需求没有得到满足,尤其是在没有保险的个人中。
{"title":"Unmet need for mental health care is common across insurance market segments in the United States.","authors":"Mark K Meiselbach, Catherine K Ettman, Karen Shen, Brian C Castrucci, Sandro Galea","doi":"10.1093/haschl/qxae032","DOIUrl":"https://doi.org/10.1093/haschl/qxae032","url":null,"abstract":"<p><p>A substantial proportion of individuals with depression in the United States do not receive treatment. While access challenges for mental health care have been documented, few recent estimates of unmet mental health needs across insurance market segments exist. Using nationally representative survey data with participant-reported depression symptom severity and mental health care use collected in Spring 2023, we assessed access to mental health care among individuals with similar levels of depression symptom severity with commercial, Medicare, Medicaid, and no insurance. Among individuals who reported symptoms consistent with moderately severe to severe depression, 37.8% did not have a diagnosis for depression (41.0%, 28.1%, 33.6%, and 56.3% with commercial, Medicare, Medicaid, and no insurance), 51.9% did not see a mental health specialist (49.7%, 51.7%, 44.9%, and 91.8%), and 32.4% avoided mental health care due to affordability in the past 12 months (30.2%, 34.0%, 21.1%, and 54.8%). There was substantial unmet need for mental health treatment in all insurance market segments, but especially among individuals without insurance.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"2 3","pages":"qxae032"},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncologic Drug Repository Programs in the United States: A Review and Comparison 美国的肿瘤药物储存库计划:回顾与比较
Pub Date : 2024-03-06 DOI: 10.1093/haschl/qxae031
Natalie K Heater, S. Kircher, Christine Weldon, J. Trosman, Al Benson
As cancer affects forty percent of all Americans during their lifetime, the financial burden of cancer care represents a significant contribution towards the overall cost of healthcare in the United States. Cancer drug repository programs offer a unique solution for patients who have limited financial ability to access medications while reducing medical waste. We reviewed all state legislation in the United States regarding cancer drug repository programs. Five states have OACD-specific drug repository programs, while 28 states have generalized drug repository programs. Iowa’s state-wide, mail-order OACD repository program is the preeminent example of an effective and efficient program which should be replicated across the country. Many states have passed legislation allowing for drug repository programs but have struggled to translate such legislation into active programs due to lack of funding and management. We offer recommendations across policy, manufacturing, institutional, healthcare professional and patient domains in order provide optimal patient care.
百分之四十的美国人一生中都会受到癌症的影响,因此癌症治疗的经济负担在美国医疗保健的总成本中占了很大比重。癌症药物储存库计划为经济能力有限的患者提供了一个独特的解决方案,既能减少医疗浪费,又能获得药物。我们审查了美国各州有关抗癌药物储存库计划的立法。其中 5 个州制定了专门针对 OACD 的药品储存库计划,28 个州制定了通用的药品储存库计划。爱荷华州的全州邮购 OACD 药品存放计划是有效和高效计划的杰出范例,应在全国范围内推广。许多州已通过立法允许实施药品储存库计划,但由于缺乏资金和管理,很难将此类立法转化为积极的计划。我们将从政策、生产、机构、医疗保健专业人员和患者等方面提出建议,以提供最佳的患者护理。
{"title":"Oncologic Drug Repository Programs in the United States: A Review and Comparison","authors":"Natalie K Heater, S. Kircher, Christine Weldon, J. Trosman, Al Benson","doi":"10.1093/haschl/qxae031","DOIUrl":"https://doi.org/10.1093/haschl/qxae031","url":null,"abstract":"\u0000 As cancer affects forty percent of all Americans during their lifetime, the financial burden of cancer care represents a significant contribution towards the overall cost of healthcare in the United States. Cancer drug repository programs offer a unique solution for patients who have limited financial ability to access medications while reducing medical waste. We reviewed all state legislation in the United States regarding cancer drug repository programs. Five states have OACD-specific drug repository programs, while 28 states have generalized drug repository programs. Iowa’s state-wide, mail-order OACD repository program is the preeminent example of an effective and efficient program which should be replicated across the country. Many states have passed legislation allowing for drug repository programs but have struggled to translate such legislation into active programs due to lack of funding and management. We offer recommendations across policy, manufacturing, institutional, healthcare professional and patient domains in order provide optimal patient care.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"3 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140260989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Access to perinatal doula services in Medicaid: a case analysis of 2 states. 在医疗补助中获得围产期陪护服务:对两个州的案例分析。
Pub Date : 2024-03-04 eCollection Date: 2024-03-01 DOI: 10.1093/haschl/qxae023
Cara B Safon, Lois McCloskey, Maria Guadalupe Estela, Sarah H Gordon, Megan B Cole, Jack Clark

Doula services support maternal and child health, but few Medicaid programs reimburse for them. Through qualitative interviews with key policy informants (n = 20), this study explored facilitators and barriers to Medicaid reimbursement through perceptions of doula-related policies in 2 states: Oregon, where doula care is reimbursed, and Massachusetts, where reimbursement is pending. Five themes characterize the inclusion of doula services in Medicaid. In Theme 1, stakeholders recognized an imperative to expand access to doula services. Subsequent themes represent complications in accomplishing that imperative. In Theme 2, perceptions that doula services were not valued by health care providers resulted in conflict between doulas and the health care system. In Theme 3, complex billing processes created friction and impeded reimbursement. In Theme 4, internal conflict presented barriers to policymaking. In Theme 5, structural fragmentation between state government and doula communities was prominent in Massachusetts, presenting tensions during policymaking. Informants reported on problems demanding resolution to establish equitable and robust doula care policies. Medicaid coverage of doula services requires ongoing collaboration with doulas, providers, and health care advocates.

朵拉服务支持母婴健康,但很少有医疗补助项目对其进行报销。通过对主要政策信息提供者(n = 20)进行定性访谈,本研究通过对两个州的朵拉相关政策的看法,探讨了医疗补助报销的促进因素和障碍:俄勒冈州的朵拉护理已获报销,马萨诸塞州的朵拉护理尚待报销。将朵拉服务纳入医疗补助有五个主题。在主题1中,利益相关者认识到扩大朵拉服务的可及性势在必行。随后的主题代表了实现这一目标的复杂性。在主题2中,朵拉服务不被医疗服务提供者重视的观点导致了朵拉与医疗系统之间的冲突。在主题3中,复杂的计费过程造成了摩擦并阻碍了报销。在主题4中,内部冲突阻碍了政策的制定。在主题 5 中,马萨诸塞州的州政府和朵拉社区之间的结构性分裂非常突出,在政策制定过程中造成了紧张关系。信息提供者报告了一些需要解决的问题,以建立公平和健全的朵拉关怀政策。朵拉服务的医疗补助(Medicaid)覆盖范围需要与朵拉、提供者和医疗保健倡导者持续合作。
{"title":"Access to perinatal doula services in Medicaid: a case analysis of 2 states.","authors":"Cara B Safon, Lois McCloskey, Maria Guadalupe Estela, Sarah H Gordon, Megan B Cole, Jack Clark","doi":"10.1093/haschl/qxae023","DOIUrl":"https://doi.org/10.1093/haschl/qxae023","url":null,"abstract":"<p><p>Doula services support maternal and child health, but few Medicaid programs reimburse for them. Through qualitative interviews with key policy informants (<i>n</i> = 20), this study explored facilitators and barriers to Medicaid reimbursement through perceptions of doula-related policies in 2 states: Oregon, where doula care is reimbursed, and Massachusetts, where reimbursement is pending. Five themes characterize the inclusion of doula services in Medicaid. In Theme 1, stakeholders recognized an imperative to expand access to doula services. Subsequent themes represent complications in accomplishing that imperative. In Theme 2, perceptions that doula services were not valued by health care providers resulted in conflict between doulas and the health care system. In Theme 3, complex billing processes created friction and impeded reimbursement. In Theme 4, internal conflict presented barriers to policymaking. In Theme 5, structural fragmentation between state government and doula communities was prominent in Massachusetts, presenting tensions during policymaking. Informants reported on problems demanding resolution to establish equitable and robust doula care policies. Medicaid coverage of doula services requires ongoing collaboration with doulas, providers, and health care advocates.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"2 3","pages":"qxae023"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Prescription drug monitoring program use by opioid prescribers: a cross-sectional study. 更正:阿片类药物处方者使用处方药监控计划的情况:一项横断面研究。
Pub Date : 2024-03-04 eCollection Date: 2024-03-01 DOI: 10.1093/haschl/qxae006

[This corrects the article DOI: 10.1093/haschl/qxad067.].

[此处更正了文章 DOI:10.1093/haschl/qxad067]。
{"title":"Correction to: Prescription drug monitoring program use by opioid prescribers: a cross-sectional study.","authors":"","doi":"10.1093/haschl/qxae006","DOIUrl":"https://doi.org/10.1093/haschl/qxae006","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/haschl/qxad067.].</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"2 3","pages":"qxae006"},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surprise billing in intensive care unit (ICU) hospitalizations. 重症监护室(ICU)住院的突击收费。
Pub Date : 2024-02-27 eCollection Date: 2024-03-01 DOI: 10.1093/haschl/qxae025
Sneha Kannan, Zirui Song

Intensive care unit (ICU) care is expensive for patients and providers, and utilization and spending on ICU resources have increased. The No Surprises Act, passed in 2022, specifically prohibits balance billing by ICU specialists (intensivists) for emergency and most non-emergency care. The potential economic impact of this remains unclear, given few data exist on the magnitude of balance billing in the ICU. Using the MarketScan Commercial (IBM) database, we studied hospitalizations in which ICU care was provided ("ICU hospitalizations") between 2010 and 2019. Hospitalizations were characterized as fully in-network, fully out-of-network, or "mixed" (contained both in- and out-of-network services). The share of "mixed" hospitalizations among all ICU hospitalizations rose from 26% to 33% over the study period. Over half of these mixed hospitalizations contained out-of-network services specifically delivered within the ICU. Total hospitalization spending averaged $81 047, with ICU spending averaging $15 799. On average, 11% of ICU spending within these hospitalizations was out-of-network. Patients were plausibly balance-billed in approximately one-third of ICU hospitalizations, for thousands of dollars per hospitalization. Given that the No Surprises Act prevents this type of balance billing, the portended revenue loss may lead to changes in provider negotiations with insurers concerning network status and prices, which could affect the care patients receive.

重症监护室 (ICU) 护理对患者和医疗服务提供者来说都是昂贵的,重症监护室资源的使用和支出也在增加。2022 年通过的《无意外法案》明确禁止 ICU 专家(重症监护专家)对急诊和大多数非急诊护理进行余额计费。由于有关 ICU 平衡计费规模的数据很少,因此其潜在的经济影响尚不明确。利用 MarketScan Commercial(IBM)数据库,我们研究了 2010 年至 2019 年期间提供 ICU 治疗的住院情况("ICU 住院")。住院治疗的特点是完全在网络内、完全在网络外或 "混合"(包含网络内和网络外服务)。在研究期间,"混合 "住院在所有重症监护病房住院中的比例从 26% 上升到 33%。在这些混合住院病例中,有一半以上是在重症监护病房内提供的网络外服务。住院总费用平均为 81047 美元,其中重症监护病房的平均费用为 15799 美元。在这些住院治疗中,ICU 平均 11% 的费用为网络外费用。约有三分之一的重症监护病房住院病人可能会收到余额账单,每次住院费用达数千美元。鉴于《无意外法案》禁止此类余额结算,预期的收入损失可能会导致医疗服务提供者与保险公司就网络地位和价格进行的谈判发生变化,从而影响患者获得的医疗服务。
{"title":"Surprise billing in intensive care unit (ICU) hospitalizations.","authors":"Sneha Kannan, Zirui Song","doi":"10.1093/haschl/qxae025","DOIUrl":"10.1093/haschl/qxae025","url":null,"abstract":"<p><p>Intensive care unit (ICU) care is expensive for patients and providers, and utilization and spending on ICU resources have increased. The No Surprises Act, passed in 2022, specifically prohibits balance billing by ICU specialists (intensivists) for emergency and most non-emergency care. The potential economic impact of this remains unclear, given few data exist on the magnitude of balance billing in the ICU. Using the MarketScan Commercial (IBM) database, we studied hospitalizations in which ICU care was provided (\"ICU hospitalizations\") between 2010 and 2019. Hospitalizations were characterized as fully in-network, fully out-of-network, or \"mixed\" (contained both in- and out-of-network services). The share of \"mixed\" hospitalizations among all ICU hospitalizations rose from 26% to 33% over the study period. Over half of these mixed hospitalizations contained out-of-network services specifically delivered within the ICU. Total hospitalization spending averaged $81 047, with ICU spending averaging $15 799. On average, 11% of ICU spending within these hospitalizations was out-of-network. Patients were plausibly balance-billed in approximately one-third of ICU hospitalizations, for thousands of dollars per hospitalization. Given that the No Surprises Act prevents this type of balance billing, the portended revenue loss may lead to changes in provider negotiations with insurers concerning network status and prices, which could affect the care patients receive.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":"2 3","pages":"qxae025"},"PeriodicalIF":0.0,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10932732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140133606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health affairs scholar
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1